Results 291 to 300 of about 7,770,494 (359)
Angubindin‐1 binds angulin‐1/‐3 at tricellular tight junctions, enhancing intestinal macromolecule permeation. Alanine scanning identified six essential residues (L562, L598, E638, V640, Y643, and K644) of angubindin‐1 critical for binding to angulin‐1/‐3 and permeation‐enhancing activity, providing insights for the development of targeted noninvasive ...
Taiki Kuzu +8 more
wiley +1 more source
Comprehensive Genomic Profiling in Advanced Non-Small Cell Lung Cancer: A Real-World Cohort Study in Finland. [PDF]
Hormalainen K +8 more
europepmc +1 more source
Antisense Oligonucleotide Therapy for Amyotrophic Lateral Sclerosis (ALS): An Umbrella Review. [PDF]
Jeong E, Li D.
europepmc +1 more source
Two Cases of Heterozygous Familial Hypercholesterolemia in Children Effectively Managed With Pitavastatin and Ezetimibe Combination Therapy. [PDF]
Nishioka K +9 more
europepmc +1 more source
Efficacy of Calcineurin Inhibition in Children With Steroid-Resistant Nephrotic Syndrome. [PDF]
Khalid M, Schwaderer AL.
europepmc +1 more source
Regarding "Challenges in diagnosing thrombotic thrombocytopenic purpura". [PDF]
Martins de Oliveira Filho C, Carney BJ.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Genetic therapy for congenital myopathies
Current Opinion in Neurology, 2021Purpose of review There has been an explosion of advancement in the field of genetic therapies. The first gene-based treatments are now in clinical practice, with several additional therapeutic programs in various stages of development.
Nika Maani, Sophie Karolczak, J. Dowling
semanticscholar +3 more sources
Clinical Trials of Genetic Therapy with Antisense DNA and DNA Vectors
, 2020A Brief History of Genetic Therapy: Gene Therapy, Antisense Technology, and Genomics, James W. Hawkins Preclinical Development of Oligonucleotide Therapeutics for Cancer: Regulatory Aspects, Chang-Ho Ahn and Joseph J.
E. Wickstrom
semanticscholar +1 more source
Transplantation Proceedings, 2005
Cellular genetic therapy is the ultimate frontier for those pathologies that are consequent to a specific nonfunctional cellular type. A viable cure for there kinds of diseases is the replacement of sick cells with healthy ones, which can be obtained from the same patient or a different donor.
Del Vecchio, F +4 more
openaire +5 more sources
Cellular genetic therapy is the ultimate frontier for those pathologies that are consequent to a specific nonfunctional cellular type. A viable cure for there kinds of diseases is the replacement of sick cells with healthy ones, which can be obtained from the same patient or a different donor.
Del Vecchio, F +4 more
openaire +5 more sources

